{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:01:57Z","timestamp":1790074917396,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.beem.2024.101935","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T12:55:27Z","timestamp":1725627327000},"page":"101935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Metabolomics and proteomics in pheochromocytoma and paraganglioma: Translating biochemistry and biology to bedside"],"prefix":"10.1016","volume":"38","author":[{"given":"Jiri","family":"Petrak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergei G.","family":"Tevosian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans K.","family":"Ghayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2024.101935_bib1","series-title":"Fathoming Metabolism","author":"Shaw","year":"2011"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib2","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3803\/EnM.2017.32.2.152","article-title":"Update on modern management of pheochromocytoma and paraganglioma","volume":"32","author":"Lenders","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"7","key":"10.1016\/j.beem.2024.101935_bib3","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1021\/acs.jproteome.2c00838","article-title":"An introduction to mass spectrometry-based proteomics","volume":"22","author":"Shuken","year":"2023","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib4","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1210\/endrev\/bnad011","article-title":"Biochemical assessment of pheochromocytoma and paraganglioma","volume":"44","author":"Eisenhofer","year":"2023","journal-title":"Endocr Rev"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib6","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib7","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"3","key":"10.1016\/j.beem.2024.101935_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41436-018-0106-5","article-title":"Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma","volume":"21","author":"Richter","year":"2019","journal-title":"Genet Med"},{"issue":"9","key":"10.1016\/j.beem.2024.101935_bib9","doi-asserted-by":"crossref","first-page":"bvae142","DOI":"10.1210\/jendso\/bvae142","article-title":"Identification of succinate dehydrogenase gene variant carriers by blood biomarkers","volume":"8","author":"Gebhardt","year":"2024","journal-title":"J Endocr Soc"},{"issue":"9","key":"10.1016\/j.beem.2024.101935_bib10","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1210\/clinem\/dgad109","article-title":"Serum succinate\/fumarate ratio in patients with paraganglioma\/pheochromocytoma attending an endocrine oncogenetic unit","volume":"108","author":"Bancel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2024.101935_bib11","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1210\/clinem\/dgac474","article-title":"Succinate: a serum biomarker of SDHB-mutated paragangliomas and pheochromocytomas","volume":"107","author":"Lamy","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib12","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1210\/clinem\/dgac653","article-title":"Somatic IDH1 hotspot variants in chinese patients with pheochromocytomas and paragangliomas","volume":"108","author":"Li","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2024.101935_bib13","doi-asserted-by":"crossref","first-page":"1274239","DOI":"10.3389\/fendo.2023.1274239","article-title":"The connection between tricarboxylic acid cycle enzyme mutations and pseudohypoxic signaling in pheochromocytoma and paraganglioma","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.beem.2024.101935_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3389\/fonc.2012.00085","article-title":"The emerging role of fumarate as an oncometabolite","volume":"2","author":"Yang","year":"2012","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.37349\/etat.2024.00222","article-title":"Tumor metabolism in pheochromocytomas: clinical and therapeutic implications","volume":"5","author":"Jeeyavudeen","year":"2024","journal-title":"Explor Target Antitumor Ther"},{"issue":"7274","key":"10.1016\/j.beem.2024.101935_bib16","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.beem.2024.101935_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ccr.2010.01.020","article-title":"The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate","volume":"17","author":"Ward","year":"2010","journal-title":"Cancer Cell"},{"issue":"15","key":"10.1016\/j.beem.2024.101935_bib18","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1111\/febs.13295","article-title":"Oncometabolites: tailoring our genes","volume":"282","author":"Nowicki","year":"2015","journal-title":"FEBS J"},{"issue":"11","key":"10.1016\/j.beem.2024.101935_bib19","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/0008-5472.CAN-20-3730","article-title":"Oncometabolites in cancer: current understanding and challenges","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res"},{"issue":"19","key":"10.1016\/j.beem.2024.101935_bib20","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1038\/s41388-020-01639-8","article-title":"The functional roles of TCA cycle metabolites in cancer","volume":"40","author":"Eniafe","year":"2021","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.beem.2024.101935_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13122900","article-title":"Metabolic rewiring and the characterization of oncometabolites","volume":"13","author":"Beyoglu","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib22","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.beem.2024.101935_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","author":"Letouze","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib24","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ecl.2019.08.006","article-title":"Pheochromocytomas and paragangliomas","volume":"48","author":"Tevosian","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib25","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1210\/jc.2017-01991","article-title":"Pheochromocytoma\/Paraganglioma: a poster child for cancer metabolism","volume":"103","author":"Tevosian","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.molcel.2015.10.017","article-title":"NADP(+)-IDH mutations promote hypersuccinylation that impairs mitochondria respiration and induces apoptosis resistance","volume":"60","author":"Li","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.beem.2024.101935_bib27","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.isci.2018.03.012","article-title":"Chromatin succinylation correlates with active gene expression and is perturbed by defective TCA cycle metabolism","volume":"2","author":"Smestad","year":"2018","journal-title":"iScience"},{"issue":"3","key":"10.1016\/j.beem.2024.101935_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3390\/metabo4030640","article-title":"The succinated proteome of FH-mutant tumours","volume":"4","author":"Yang","year":"2014","journal-title":"Metabolites"},{"key":"10.1016\/j.beem.2024.101935_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tibs.2024.05.003","article-title":"Functional implications of fumarate-induced cysteine succination","author":"Guberovic","year":"2024","journal-title":"Trends Biochem Sci"},{"issue":"11","key":"10.1016\/j.beem.2024.101935_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1530\/ERC-20-0205","article-title":"HIF2alpha supports pro-metastatic behavior in pheochromocytomas\/paragangliomas","volume":"27","author":"Bechmann","year":"2020","journal-title":"Endocr Relat Cancer"},{"issue":"13","key":"10.1016\/j.beem.2024.101935_bib31","doi-asserted-by":"crossref","first-page":"4551","DOI":"10.1016\/j.celrep.2020.03.022","article-title":"TET-mediated hypermethylation primes SDH-deficient cells for HIF2alpha-driven mesenchymal transition","volume":"30","author":"Morin","year":"2020","journal-title":"Cell Rep"},{"issue":"9","key":"10.1016\/j.beem.2024.101935_bib32","doi-asserted-by":"crossref","first-page":"3652","DOI":"10.1172\/JCI67228","article-title":"Oncometabolites: linking altered metabolism with cancer","volume":"123","author":"Yang","year":"2013","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.beem.2024.101935_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ccr.2013.05.015","article-title":"Succinate: a new epigenetic hacker","volume":"23","author":"Yang","year":"2013","journal-title":"Cancer Cell"},{"issue":"11","key":"10.1016\/j.beem.2024.101935_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080539","article-title":"A new specific succinate-glutamate metabolomic hallmark in SDHx-related paragangliomas","volume":"8","author":"Imperiale","year":"2013","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.beem.2024.101935_bib35","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1210\/jc.2014-2151","article-title":"Krebs cycle metabolite profiling for identification and stratification of pheochromocytomas\/paragangliomas due to succinate dehydrogenase deficiency","volume":"99","author":"Richter","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib36","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neo.2014.10.010","article-title":"Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications","volume":"17","author":"Imperiale","year":"2015","journal-title":"Neoplasia"},{"issue":"8","key":"10.1016\/j.beem.2024.101935_bib37","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.cell.2023.01.038","article-title":"What is cancer metabolism?","volume":"186","author":"Finley","year":"2023","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.beem.2024.101935_bib38","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/ncb3233","article-title":"Pyruvate carboxylation enables growth of SDH-deficient cells by supporting aspartate biosynthesis","volume":"17","author":"Cardaci","year":"2015","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.beem.2024.101935_bib39","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/ncomms9784","article-title":"Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism","volume":"6","author":"Lussey-Lepoutre","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.beem.2024.101935_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78654","article-title":"Mitochondrial redox adaptations enable alternative aspartate synthesis in SDH-deficient cells","volume":"12","author":"Hart","year":"2023","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.beem.2024.101935_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12030599","article-title":"Glutaminases as a novel target for SDHB-associated pheochromocytomas\/paragangliomas","volume":"12","author":"Sarkadi","year":"2020","journal-title":"Cancers"},{"issue":"14","key":"10.1016\/j.beem.2024.101935_bib42","doi-asserted-by":"crossref","first-page":"3787","DOI":"10.1158\/1078-0432.CCR-12-3922","article-title":"Genotype-specific abnormalities in mitochondrial function associate with distinct profiles of energy metabolism and catecholamine content in pheochromocytoma and paraganglioma","volume":"19","author":"Rao","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib43","doi-asserted-by":"crossref","first-page":"E214","DOI":"10.1210\/jc.2014-2138","article-title":"Genotype-specific differences in the tumor metabolite profile of pheochromocytoma and paraganglioma using untargeted and targeted metabolomics","volume":"100","author":"Rao","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.beem.2024.101935_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104761","article-title":"An evolving view of complex II-noncanonical complexes, megacomplexes, respiration, signaling, and beyond","volume":"299","author":"Iverson","year":"2023","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1096\/fj.201901456R","article-title":"Succinate dehydrogenase deficiency in a chromaffin cell model retains metabolic fitness through the maintenance of mitochondrial NADH oxidoreductase function","volume":"34","author":"Kluckova","year":"2020","journal-title":"FASEB J"},{"issue":"6","key":"10.1016\/j.beem.2024.101935_bib46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1530\/ERC-22-0030","article-title":"Preclinical evaluation of targeted therapies in Sdhb-mutated tumors","volume":"29","author":"Moog","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"Pt B)","key":"10.1016\/j.beem.2024.101935_bib47","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ymben.2016.11.005","article-title":"Dual loss of succinate dehydrogenase (SDH) and complex I activity is necessary to recapitulate the metabolic phenotype of SDH mutant tumors","volume":"43","author":"Lorendeau","year":"2017","journal-title":"Metab Eng"},{"issue":"33","key":"10.1016\/j.beem.2024.101935_bib48","doi-asserted-by":"crossref","first-page":"25130","DOI":"10.1074\/jbc.M001914200","article-title":"Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1alpha during hypoxia: a mechanism of O2 sensing","volume":"275","author":"Chandel","year":"2000","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1128\/MCB.01338-07","article-title":"Loss of the SdhB, but Not the SdhA, subunit of complex II triggers reactive oxygen species-dependent hypoxia-inducible factor activation and tumorigenesis","volume":"28","author":"Guzy","year":"2008","journal-title":"Mol Cell Biol"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104624","article-title":"H(2)O(2) transit through the mitochondrial intermembrane space promotes tumor cell growth in vitro and in vivo.","volume":"299","author":"Sabharwal","year":"2023","journal-title":"J Biol Chem"},{"issue":"23","key":"10.1016\/j.beem.2024.101935_bib51","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1016\/j.molcel.2022.10.005","article-title":"Reversal of mitochondrial malate dehydrogenase 2 enables anaplerosis via redox rescue in respiration-deficient cells","volume":"82","author":"Altea-Manzano","year":"2022","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.beem.2024.101935_bib52","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1158\/1078-0432.CCR-16-2250","article-title":"Targeted exome sequencing of Krebs cycle genes reveals candidate cancer-predisposing mutations in pheochromocytomas and paragangliomas","volume":"23","author":"Remacha","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib53","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jnci\/djab158","article-title":"Germline SUCLG2 variants in patients with pheochromocytoma and paraganglioma","volume":"114","author":"Hadrava Vanova","year":"2022","journal-title":"J Natl Cancer Inst"},{"issue":"268","key":"10.1016\/j.beem.2024.101935_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","author":"Killian","year":"2014","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.beem.2024.101935_bib55","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2015-3856","article-title":"Epigenetic mutation of the succinate dehydrogenase C promoter in a patient with two paragangliomas","volume":"101","author":"Richter","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib56","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.5472","article-title":"Metabolomics, machine learning and immunohistochemistry to predict succinate dehydrogenase mutational status in phaeochromocytomas and paragangliomas","volume":"251","author":"Wallace","year":"2020","journal-title":"J Pathol"},{"issue":"8","key":"10.1016\/j.beem.2024.101935_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/metabo12080755","article-title":"Predicting hypertension subtypes with machine learning using targeted metabolites and their ratios","volume":"12","author":"Reel","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.beem.2024.101935_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104276","article-title":"Machine learning for classification of hypertension subtypes using multi-omics: a multi-centre, retrospective, data-driven study","volume":"84","author":"Reel","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib59","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41746-021-00549-7","article-title":"Guidelines and quality criteria for artificial intelligence-based prediction models in healthcare: a scoping review","volume":"5","author":"de Hond","year":"2022","journal-title":"NPJ Digit Med"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib60","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/a-1440-0278","article-title":"Adrenal hormone interactions and metabolism: a single sample multi-omics approach","volume":"53","author":"Bechmann","year":"2021","journal-title":"Horm Metab Res"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib61","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1074\/mcp.M115.053702","article-title":"Simultaneous metabolite, protein, lipid extraction (SIMPLEX): a combinatorial multimolecular omics approach for systems biology","volume":"15","author":"Coman","year":"2016","journal-title":"Mol Cell Proteom"},{"issue":"9","key":"10.1016\/j.beem.2024.101935_bib62","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1021\/acs.jproteome.8b00199","article-title":"Simultaneous extraction of RNA and metabolites from single kidney tissue specimens for combined transcriptomic and metabolomic profiling","volume":"17","author":"Leuthold","year":"2018","journal-title":"J Proteome Res"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib63","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/15476286.2023.2204586","article-title":"Prior metabolite extraction fully preserves RNAseq quality and enables integrative multi-'omics analysis of the liver metabolic response to viral infection","volume":"20","author":"Madaj","year":"2023","journal-title":"RNA Biol"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib64","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Tomlinson","year":"2002","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.beem.2024.101935_bib65","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1210\/clinem\/dgac386","article-title":"Fumarate hydratase is a novel gene for familial non-medullary thyroid cancer","volume":"107","author":"Alzahrani","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.beem.2024.101935_bib66","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41416-023-02412-w","article-title":"Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism","volume":"129","author":"Valcarcel-Jimenez","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/j.beem.2024.101935_bib67","doi-asserted-by":"crossref","first-page":"1381093","DOI":"10.3389\/fendo.2024.1381093","article-title":"Genetic changes in the FH gene cause vagal paraganglioma","volume":"15","author":"Snezhkina","year":"2024","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/PAS.0000000000001945","article-title":"A clinicopathologic and molecular analysis of fumarate hydratase-deficient pheochromocytoma and paraganglioma","volume":"47","author":"Fuchs","year":"2023","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.beem.2024.101935_bib69","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","author":"Castro-Vega","year":"2015","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.beem.2024.101935_bib70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278108","article-title":"Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)","volume":"17","author":"Ricketts","year":"2022","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib71","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.euf.2021.12.002","article-title":"Genomic and metabolic hallmarks of SDH- and FH-deficient renal cell carcinomas","volume":"8","author":"Yoo","year":"2022","journal-title":"Eur Urol Focus"},{"issue":"12","key":"10.1016\/j.beem.2024.101935_bib72","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1038\/bjc.2017.361","article-title":"Global metabolomic profiling of uterine leiomyomas","volume":"117","author":"Heinonen","year":"2017","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib73","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/2049-3002-1-12","article-title":"Reversed argininosuccinate lyase activity in fumarate hydratase-deficient cancer cells","volume":"1","author":"Zheng","year":"2013","journal-title":"Cancer Metab"},{"issue":"4","key":"10.1016\/j.beem.2024.101935_bib74","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41581-023-00800-2","article-title":"Metabolic alterations in hereditary and sporadic renal cell carcinoma","volume":"20","author":"Coffey","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"10.1016\/j.beem.2024.101935_bib75","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165028","article-title":"Circulating succinate-modifying metabolites accurately classify and reflect the status of fumarate hydratase-deficient renal cell carcinoma","volume":"133","author":"Zheng","year":"2023","journal-title":"J Clin Invest"},{"issue":"7363","key":"10.1016\/j.beem.2024.101935_bib76","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature10363","article-title":"Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase","volume":"477","author":"Frezza","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv053","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","author":"Cascon","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib78","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajhg.2016.11.014","article-title":"Mutations in MDH2, encoding a Krebs cycle enzyme, cause early-onset severe encephalopathy","volume":"100","author":"Ait-El-Mkadem","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.beem.2024.101935_bib79","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1128\/MCB.01223-06","article-title":"Multiple factors affecting cellular redox status and energy metabolism modulate hypoxia-inducible factor prolyl hydroxylase activity in vivo and in vitro","volume":"27","author":"Pan","year":"2007","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.beem.2024.101935_bib80","doi-asserted-by":"crossref","first-page":"1070074","DOI":"10.3389\/fendo.2022.1070074","article-title":"Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma","volume":"13","author":"Mellid","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.beem.2024.101935_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111218","article-title":"Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer","volume":"40","author":"Gupta","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.beem.2024.101935_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154297","article-title":"Targeting pheochromocytoma\/paraganglioma with polyamine inhibitors","volume":"110","author":"Rai","year":"2020","journal-title":"Metabolism"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib83","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14162","article-title":"Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma","volume":"54","author":"Ghayee","year":"2024","journal-title":"Eur J Clin Invest"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib84","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.18632\/oncotarget.23639","article-title":"Characterization and metabolic synthetic lethal testing in a new model of SDH-loss familial pheochromocytoma and paraganglioma","volume":"9","author":"Smestad","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.beem.2024.101935_bib85","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.598656","article-title":"Seven novel genes related to cell proliferation and migration of VHL-mutated pheochromocytoma","volume":"12","author":"Gao","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib86","doi-asserted-by":"crossref","first-page":"E1223","DOI":"10.1152\/ajpendo.90591.2008","article-title":"Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma","volume":"295","author":"Eisenhofer","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.beem.2024.101935_bib87","doi-asserted-by":"crossref","first-page":"22057","DOI":"10.1002\/jcp.28769","article-title":"From clinic to mechanism: proteomics-based assessment of angiogenesis in adrenal pheochromocytoma","volume":"234","author":"Sun","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.beem.2024.101935_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jprot.2016.08.006","article-title":"Integral membrane proteins in proteomics. How to break open the black box?","volume":"153","author":"Vit","year":"2017","journal-title":"J Proteom"},{"issue":"21","key":"10.1016\/j.beem.2024.101935_bib89","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26216567","article-title":"Deep membrane proteome profiling reveals overexpression of prostate-specific membrane antigen (PSMA) in high-risk human paraganglioma and pheochromocytoma, suggesting new theranostic opportunity","volume":"26","author":"Vit","year":"2021","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.beem.2024.101935_bib90","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/oncolo\/oyac279","article-title":"PSMA-targeted radiopharmaceuticals in prostate cancer: current data and new trials","volume":"28","author":"Ramnaraign","year":"2023","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.beem.2024.101935_bib91","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12014-023-09428-7","article-title":"Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization","volume":"20","author":"Vit","year":"2023","journal-title":"Clin Proteom"},{"issue":"7","key":"10.1016\/j.beem.2024.101935_bib92","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/cac2.12427","article-title":"DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling","volume":"43","author":"Mellid","year":"2023","journal-title":"Cancer Commun (Lond)"}],"container-title":["Best Practice & Research Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X24001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T18:01:15Z","timestamp":1737309675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X24001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1521690X24001106"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2024.101935","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics and proteomics in pheochromocytoma and paraganglioma: Translating biochemistry and biology to bedside","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2024.101935","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101935"}}